J Korean Neurol Assoc.  1986 Dec;4(2):231-234.

Paraplegia following Chemonucleolysis A Case Report and Discussion of Neurotoxicity

Affiliations
  • 1Department of Neurology, College of Medicine, Hanyang University.

Abstract

Chymopapain was discovered by Jensen in 1941, and in 1963 Smith demonstrated the chondrolytic properties of chymopapain. Since then, many patients have been injected with this agent. Although there are evidences of neurotoxicity to chymopapain in animals, adverse effects in humans have rarely been reported. We present a case delayed onset of paraplegia after chymopapain chemonucleolysis and review the neurotoxicities to chymopapain.


MeSH Terms

Animals
Chymopapain
Humans
Intervertebral Disc Chemolysis*
Paraplegia*
Chymopapain
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr